Association Between Empirical Anti-Pseudomonal Antibiotics for Recurrent Lower Respiratory Tract Infections and Mortality: A Retrospective Cohort Study

References

• Dang TT, Majumdar SR, Marrie TJ, Eurich DT. Recurrent pneumonia: a review with focus on clinical epidemiology and modifiable risk factors in elderly patients. Drugs Aging. 2015;32(1):13–19. doi:10.1007/s40266-014-0229-6
   PubMed Web of Science ®Google Scholar
• Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128–1138. doi:10.1056/NEJMoa0909883
   PubMed Web of Science ®Google Scholar
• Almirall J, Serra-Prat M, Bolíbar I, Balasso V. Risk factors for community-acquired pneumonia in adults: a systematic review of observational studies. Respiration. 2017;94(3):299–311. doi:10.1159/000479089
   PubMed Web of Science ®Google Scholar
• Garcia-Vidal C, Almagro P, Romaní V, et al. Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study. Eur Respir J. 2009;34(5):1072–1078. doi:10.1183/09031936.00003309
   PubMed Web of Science ®Google Scholar
• Eklöf J, Sørensen R, Ingebrigtsen TS, et al. Pseudomonas aeruginosa and risk of death and exacerbations in patients with chronic obstructive pulmonary disease: an observational cohort study of 22 053 patients. Clin Microbiol Infect. 2020;26(2):227–234. doi:10.1016/j.cmi.2019.06.011
   PubMed Web of Science ®Google Scholar
• Sibila O, Laserna E, Maselli DJ, et al. Risk factors and antibiotic therapy in P aeruginosa community-acquired pneumonia. Respirology. 2015;20(4):660–666. doi:10.1111/resp.12506
   PubMed Web of Science ®Google Scholar
• Cillóniz C, Gabarrús A, Ferrer M, et al. Community-acquired pneumonia due to multidrug- and non-multidrug-resistant Pseudomonas aeruginosa. Chest. 2016;150(2):415–425. doi:10.1016/j.chest.2016.03.042
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Gold reports; 2022. Available from: https://goldcopd.org/2022-gold-reports/. Accessed November 30, 2021.
   Google Scholar
• Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200(7):e45–e67. doi:10.1164/rccm.201908-1581ST
   PubMed Web of Science ®Google Scholar
• Attridge RT, Frei CR, Restrepo MI, et al. Guideline-concordant therapy and outcomes in healthcare-associated pneumonia. Eur Respir J. 2011;38(4):878–887. doi:10.1183/09031936.00141110
   PubMed Web of Science ®Google Scholar
• Rothberg MB, Zilberberg MD, Pekow PS, et al. Association of guideline-based antimicrobial therapy and outcomes in healthcare-associated pneumonia. J Antimicrob Chemother. 2015;70(5):1573–1579. doi:10.1093/jac/dku533
   PubMed Web of Science ®Google Scholar
• Webb BJ, Sorensen J, Jephson A, Mecham I, Dean NC. Broad-spectrum antibiotic use and poor outcomes in community-onset pneumonia: a cohort study. Eur Respir J. 2019;54(1):1900057. doi:10.1183/13993003.00057-2019
   PubMed Web of Science ®Google Scholar
• Sando E, Suzuki M, Ishida M, et al. Definitive and indeterminate Pseudomonas aeruginosa infection in adults with community-acquired pneumonia: a prospective observational study. Ann Am Thorac Soc. 2021;18(9):1475–1481. doi:10.1513/AnnalsATS.201906-459OC
   PubMed Web of Science ®Google Scholar
• Shiroshita A, Miyakoshi C, Tsutsumi S, et al. Effectiveness of empirical anti-pseudomonal antibiotics for recurrent COPD exacerbation: a multicenter retrospective cohort study. Sci Rep. 2021;11(1):20066. doi:10.1038/s41598-021-99640-y
   PubMed Web of Science ®Google Scholar
• Benchimol EI, Smeeth L, Guttmann A, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLOS Med. 2015;12(10):e1001885. doi:10.1371/journal.pmed.1001885
   PubMed Web of Science ®Google Scholar
• Tabak YP, Sun X, Johannes RS, Gupta V, Shorr AF. Mortality and need for mechanical ventilation in acute exacerbations of chronic obstructive pulmonary disease: development and validation of a simple risk score. Arch Intern Med. 2009;169(17):1595–1602. doi:10.1001/archinternmed.2009.270
   PubMedGoogle Scholar
• Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243–250. doi:10.1056/NEJM199701233360402
   PubMed Web of Science ®Google Scholar
• Webb BJ, Dascomb K, Stenehjem E, Dean N. Predicting risk of drug-resistant organisms in pneumonia: moving beyond the HCAP model. Respir Med. 2015;109(1):1–10. doi:10.1016/j.rmed.2014.10.017
   PubMed Web of Science ®Google Scholar
• Shindo Y, Ito R, Kobayashi D, et al. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2013;188(8):985–995. doi:10.1164/rccm.201301-0079OC
   PubMed Web of Science ®Google Scholar
• Baggs J, Jernigan JA, Halpin AL, Epstein L, Hatfield KM, McDonald LC. Risk of subsequent sepsis within 90 days after a hospital stay by type of antibiotic exposure. Clin Infect Dis. 2018;66(7):1004–1012. doi:10.1093/cid/cix947
   PubMed Web of Science ®Google Scholar
• Shehab N, Patel PR, Srinivasan A, Budnitz DS. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis. 2008;47(6):735–743. doi:10.1086/591126
   PubMed Web of Science ®Google Scholar
• Chalmers JD, Al-Khairalla M, Short PM, Fardon TC, Winter JH. Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic. J Antimicrob Chemother. 2010;65(4):608–618. doi:10.1093/jac/dkq038
   PubMed Web of Science ®Google Scholar
• Freedberg DE, Salmasian H, Cohen B, Abrams JA, Larson EL. Receipt of antibiotics in hospitalized patients and risk for Clostridium difficile infection in subsequent patients who occupy the same bed. JAMA Intern Med. 2016;176(12):1801–1808. doi:10.1001/jamainternmed.2016.6193
   PubMed Web of Science ®Google Scholar
• Gross AE, Van Schooneveld TC, Olsen KM, et al. Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia. Antimicrob Agents Chemother. 2014;58(9):5262–5268. doi:10.1128/AAC.02582-14
   PubMed Web of Science ®Google Scholar
• Almagro P, Salvadó M, Garcia-Vidal C, et al. Pseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary disease. Respiration. 2012;84(1):36–43. doi:10.1159/000331224
   PubMed Web of Science ®Google Scholar
• Fine MJ, Smith MA, Carson CA, et al. Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA. 1996;275(2):134–141. doi:10.1001/jama.275.2.134
   PubMed Web of Science ®Google Scholar
• Quintana JM, Esteban C, Unzurrunzaga A, et al. Predictive score for mortality in patients with COPD exacerbations attending hospital emergency departments. BMC Med. 2014;12(1):66. doi:10.1186/1741-7015-12-66
   PubMed Web of Science ®Google Scholar
• Yamana H, Moriwaki M, Horiguchi H, Kodan M, Fushimi K, Yasunaga H. Validity of diagnoses, procedures, and laboratory data in Japanese administrative data. J Epidemiol. 2017;27(10):476–482. doi:10.1016/j.je.2016.09.009
   PubMed Web of Science ®Google Scholar